Drug Repurposing in the Treatment of Traumatic Brain Injury

Traumatic brain injury (TBI) is the most common cause of morbidity among trauma patients; however, an effective pharmacological treatment has not yet been approved. Individuals with TBI are at greater risk of developing neurological illnesses such as Alzheimer’s disease (AD) and Parkinson’s disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghiam, Michael K., Patel, Shrey D., Hoffer, Alan, Selman, Warren R., Hoffer, Barry J., Hoffer, Michael E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021906/
https://www.ncbi.nlm.nih.gov/pubmed/33833663
http://dx.doi.org/10.3389/fnins.2021.635483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021906/
https://www.ncbi.nlm.nih.gov/pubmed/33833663
http://dx.doi.org/10.3389/fnins.2021.635483

Ejemplares similares